ALXO - Alx Oncology Holdings Inc
IEX Last Trade
2.33
0.030 1.288%
Share volume: 860,690
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.30
0.03
1.30%
Summary score
25%
Profitability
25%
Dept financing
2%
Liquidity
50%
Performance
24%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-11.46%
Return on assets
-7.65%
Return on sales
-1085.59%
Return on invested capital
256.32%
Total debt ratio
10.33%
Debt ratio change over timeo
-0.95%
Current Ratio
19.98%
Quick Ratio
0%
Cash Position Ratio
19.52%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.46%
Return on assets
-7.65%
Return on sales
-1423.59%
Return on invested capital
256.32%
Total debt ratio
10.33%
Debt ratio change over timeo
-0.95%
Current Ratio
19.98%
Quick Ratio
0%
Cash Position Ratio
19.52%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-15.41%
Return on assets
-10.46%
Return on sales
-2046.87%
Return on invested capital
265.07%
Total debt ratio
12.09%
Debt ratio change over time
-0.95%
Current Ratio
13.04%
Quick Ratio
0%
Cash Position Ratio
12.71%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-106.23%
Return on assets
-104.23%
Return on sales
-926.78%
Return on invested capital
7.07%
Total debt ratio
-95.12%
Debt ratio change over time
-0.95%
Current Ratio
4.27%
Quick Ratio
0%
Cash Position Ratio
4.13%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALXO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -11.46% | -3.05% | 11.55% | 6.27% |
| Return on assets | -7.65% | 3.6% | 3.57% | 5.27% |
| Return on sales | -1085.59% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 256.32% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 59% |
| Total debt ratio | 10.33% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.95% | 6.09% | 6.03% | 1.53% |
| Dept financing | 3% | 50% | 43% | 14% |
| Current Ratio | 19.98% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 19.52% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 13% | 30% | 29% |
| Short-term ratios | ALXO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -11.46% | -25.62% | 17.94% | 7.14% |
| Return on assets | -7.65% | 3.26% | 3.67% | 4.71% |
| Return on sales | -1423.59% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 256.32% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 59% |
| Total debt ratio | 10.33% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.95% | -23.44% | 9.66% | 0.6% |
| Dept financing | 2% | 25% | 45% | 8% |
| Current Ratio | 19.98% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 19.52% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 22% | 18% | 31% |